Masimo Co. (NASDAQ:MASI) Shares Sold by New York State Teachers Retirement System

New York State Teachers Retirement System trimmed its position in Masimo Co. (NASDAQ:MASI) by 0.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 45,248 shares of the medical equipment provider’s stock after selling 200 shares during the quarter. New York State Teachers Retirement System’s holdings in Masimo were worth $7,479,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently bought and sold shares of the company. Allspring Global Investments Holdings LLC boosted its holdings in Masimo by 1,936.9% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 48,764 shares of the medical equipment provider’s stock valued at $8,220,000 after purchasing an additional 46,370 shares during the last quarter. Louisiana State Employees Retirement System raised its stake in shares of Masimo by 0.8% in the 4th quarter. Louisiana State Employees Retirement System now owns 12,300 shares of the medical equipment provider’s stock valued at $2,033,000 after acquiring an additional 100 shares during the period. Empowered Funds LLC raised its stake in shares of Masimo by 85.7% in the 4th quarter. Empowered Funds LLC now owns 3,891 shares of the medical equipment provider’s stock valued at $643,000 after acquiring an additional 1,796 shares during the period. Lecap Asset Management Ltd. purchased a new stake in shares of Masimo in the 4th quarter valued at approximately $1,607,000. Finally, Sumitomo Mitsui Trust Group Inc. raised its stake in shares of Masimo by 0.4% in the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 373,705 shares of the medical equipment provider’s stock valued at $61,773,000 after acquiring an additional 1,522 shares during the period. 85.96% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

MASI has been the topic of a number of research analyst reports. Needham & Company LLC reissued a “hold” rating on shares of Masimo in a research note on Wednesday, January 22nd. Piper Sandler boosted their price target on shares of Masimo from $180.00 to $210.00 and gave the company an “overweight” rating in a research note on Wednesday, December 18th. Raymond James boosted their price target on shares of Masimo from $170.00 to $194.00 and gave the company an “outperform” rating in a research note on Friday, December 27th. Wells Fargo & Company boosted their price target on shares of Masimo from $171.00 to $193.00 and gave the company an “overweight” rating in a research note on Wednesday, December 11th. Finally, Stifel Nicolaus reaffirmed a “buy” rating and set a $190.00 target price (up from $170.00) on shares of Masimo in a research note on Friday, November 22nd. Two research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, Masimo has an average rating of “Moderate Buy” and a consensus target price of $191.40.

Masimo Price Performance

Shares of MASI opened at $179.43 on Thursday. Masimo Co. has a fifty-two week low of $101.61 and a fifty-two week high of $184.51. The firm’s 50 day moving average price is $172.86 and its 200 day moving average price is $151.11. The company has a market cap of $9.61 billion, a P/E ratio of 123.74 and a beta of 1.02. The company has a quick ratio of 1.11, a current ratio of 2.01 and a debt-to-equity ratio of 0.50.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.